| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 137 |
| 1 | CARMUSTINE | 88 |
| 2 | CYTARABINE | 86 |
| 3 | MELPHALAN HYDROCHLORIDE | 85 |
| 4 | CISPLATIN | 74 |
| 5 | PREDNISONE | 74 |
| 6 | GEFITINIB | 70 |
| 7 | CYCLOPHOSPHAMIDE | 65 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 65 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 65 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CARMUSTINE | 88 | 0.0187 |
| 1 | GEFITINIB | 70 | 0.0078 |
| 2 | CHLORAMBUCIL | 25 | 0.0064 |
| 3 | MELPHALAN HYDROCHLORIDE | 85 | 0.0034 |
| 4 | IFOSFAMIDE FOR INJECTION | 57 | 0.0027 |
| 5 | ERLOTINIB HYDROCHLORIDE | 24 | 0.0019 |
| 6 | ETOPOSIDE | 137 | 0.0019 |
| 7 | SELUMETINIB | 3 | 0.0018 |
| 8 | CYTARABINE | 86 | 0.0014 |
| 9 | AFATINIB | 9 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 137 |
| 1 | Platinum-based Drug [EPC] | 123 |
| 2 | Alkylating Drug [EPC] | 117 |
| 3 | Kinase Inhibitor [EPC] | 98 |
| 4 | Corticosteroid [EPC] | 92 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 89 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 84 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 55 |
| 8 | Xanthine Oxidase Inhibitor [EPC] | 26 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 137 | 0.0018 |
| 1 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 2 | Alkylating Drug [EPC] | 117 | 0.0005 |
| 3 | Platinum-based Drug [EPC] | 123 | 0.0004 |
| 4 | Polyene Antifungal [EPC] | 18 | 0.0004 |
| 5 | Androgen [EPC] | 9 | 0.0003 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 89 | 0.0003 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 7 | 0.0003 |
| 8 | Radioligand Therapeutic Agent [EPC] | 3 | 0.0002 |
| 9 | Progestin Antagonist [EPC] | 1 | 0.0002 |